XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 82 filers reported holding XENON PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,139,029 | -11.3% | 413,906 | 0.0% | 0.25% | -5.6% |
| Q2 2023 | $15,935,381 | -30.6% | 413,906 | -35.4% | 0.27% | -36.1% |
| Q1 2023 | $22,948,548 | -9.2% | 641,200 | 0.0% | 0.42% | -15.6% |
| Q4 2022 | $25,282,516 | +9.2% | 641,200 | 0.0% | 0.50% | +9.7% |
| Q3 2022 | $23,147,000 | +62.0% | 641,200 | +36.5% | 0.46% | +48.7% |
| Q2 2022 | $14,288,000 | -48.5% | 469,700 | -68.5% | 0.31% | -18.0% |
| Q2 2021 | $27,744,000 | +4.0% | 1,490,000 | 0.0% | 0.37% | -5.6% |
| Q1 2021 | $26,671,000 | +68.3% | 1,490,000 | +44.6% | 0.40% | +62.6% |
| Q4 2020 | $15,844,000 | +12.3% | 1,030,140 | -19.1% | 0.24% | -12.0% |
| Q3 2020 | $14,104,000 | -11.7% | 1,274,100 | 0.0% | 0.28% | -20.5% |
| Q2 2020 | $15,977,000 | +10.6% | 1,274,100 | 0.0% | 0.35% | -25.9% |
| Q1 2020 | $14,448,000 | -13.5% | 1,274,100 | 0.0% | 0.47% | -0.6% |
| Q4 2019 | $16,703,000 | +45.5% | 1,274,100 | 0.0% | 0.47% | +24.3% |
| Q3 2019 | $11,480,000 | -8.6% | 1,274,100 | 0.0% | 0.38% | -0.8% |
| Q2 2019 | $12,563,000 | +99.2% | 1,274,100 | +105.3% | 0.38% | +76.0% |
| Q1 2019 | $6,306,000 | +135.5% | 620,691 | +46.2% | 0.22% | +82.4% |
| Q4 2018 | $2,678,000 | -35.6% | 424,433 | +34.7% | 0.12% | -22.2% |
| Q3 2018 | $4,158,000 | – | 315,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,594,932 | $57,577,000 | 9.26% |
| GREAT POINT PARTNERS LLC | 850,000 | $30,685,000 | 7.39% |
| ACUTA CAPITAL PARTNERS, LLC | 272,500 | $9,837,000 | 4.24% |
| DAFNA Capital Management LLC | 375,223 | $13,546,000 | 3.64% |
| Redmile Group, LLC | 2,370,614 | $85,579,000 | 3.32% |
| Avoro Capital Advisors LLC | 4,900,000 | $176,890,000 | 3.27% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 245,992 | $8,880,000 | 3.00% |
| Nan Fung Group Holdings Ltd | 114,380 | $4,129,000 | 2.64% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,504,020 | $162,595,000 | 2.46% |
| Parkman Healthcare Partners LLC | 222,597 | $8,036,000 | 2.28% |